This study concern a prospective cohort pf patients with latent prostate cancer. We study the specific survival at 10 years of patients who accept an active control.Patients inclusion are realized in 2 stages: * patient with inclusion criteria (PSA \< 10 ng/ml, clinical stage T1c or T2a, Gleason \< or = 6) are registered if they accept a second prostate biopsy in a 3 months delay * after analyse of second biopsy in central laboratory and confirmation of latent prostate biopsy, patients are included if they accept active control Included patients will have 1 biopsy by years the first two years and then 1 biopsy each 2 years during 8 years. If progression of cancer happens during the 10 years control, active control will be stopped and patient will be treated by surgery and chemotherapy.
This study concern the active control during 10 years of patient with latent prostate cancer who accept not be treated immediately.
Study Type
OBSERVATIONAL
Enrollment
100
patient of control group will have : * 1 prostate biopsy 3 months after diagnostic biopsy * 1 prostate biopsy each year during 2 years * 1 prostate biopsy each 2 years during 8 years
R Azzouzi
Angers, France
Jean-Louis DAVIN
Avignon, France
Henri BENSADOUN
Caen, France
SALOMON
Créteil, France
René GASCHIGNARD
La Roche-sur-Yon, France
RUFFION
Lyon, France
Eric LECHEVALLIER
Marseille, France
P. ROSSI
Marseille, France
Xavier REBILLARD
Montpellier, France
RIGAUD Jérôme
Nantes, France
...and 5 more locations
Evaluates specific survival to 10 years
Time frame: 10 years
To evaluate acceptation of 2nd biopsy to confirm latent cancer
Time frame: 10 years
To evaluate global survival of patient in control
Time frame: 10 years
To evaluate the survival of patient with a secondary active treatment after a control period
Time frame: 10 years
To evaluate delay to secondary treatment after a period control
Time frame: 10 years
To evaluate survival rate without biological or clinical progression of cancer
Time frame: 10 years
To evaluate quality of life
Time frame: 10 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.